down arrow

Emcure Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
909.70
3.9 (0.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 32.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Net Sales
5,779.75
4,886.89
Other Operating Income
0.00
0.00
Total Operating income
5,779.75
4,886.89
Raw Material Cost
1,123.03
960.34
Purchase of Finished goods
1,311.38
963.09
(Increase) / Decrease In Stocks
-179.91
-119.01
Employee Cost
1,072.92
953.57
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
Other Expenses
1,373.39
1,210.53
Total Expenditure (Excl Depreciation)
4,700.81
3,968.53
Operating Profit (PBDIT) excl Other Income
1,078.94
918.36
Other Income
55.86
45.25
Operating Profit (PBDIT)
1,134.80
963.61
Interest
136.76
171.66
Exceptional Items
0.00
-9.79
Gross Profit (PBDT)
998.04
782.16
Depreciation
287.30
221.84
Profit Before Tax
710.74
560.33
Tax
200.51
153.77
Provisions and contingencies
0.00
0.00
Profit After Tax
510.23
406.56
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
510.23
406.56
Share in Profit of Associates
0.00
0.00
Minority Interest
-13.12
-10.94
Other related items
0.00
0.00
Consolidated Net Profit
492.37
383.01
Equity Capital
189.43
180.85
Face Value
10.0
10.0
Reserves
0.00
0.00
Diluted Earnings per share
8.12
6.27
Operating Profit Margin (Excl OI)
18.67%
18.79%
Gross Profit Margin
17.27%
16.01%
PAT Margin
8.83%
8.32%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 19.60%

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 58.80%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 14.62%

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is -29.80%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of Emcure Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
5,779.75
9,199.93
-3,420.18
-37.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,779.75
9,199.93
-3,420.18
-37.18%
Raw Material Cost
1,123.03
1,471.08
-348.05
-23.66%
Purchase of Finished goods
1,311.38
1,244.57
66.81
5.37%
(Increase) / Decrease In Stocks
-179.91
-93.01
-86.90
-93.43%
Employee Cost
1,072.92
1,989.92
-917.00
-46.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,373.39
2,225.77
-852.38
-38.30%
Total Expenditure (Excl Depreciation)
4,700.81
6,838.33
-2,137.52
-31.26%
Operating Profit (PBDIT) excl Other Income
1,078.94
2,361.60
-1,282.66
-54.31%
Other Income
55.86
287.35
-231.49
-80.56%
Operating Profit (PBDIT)
1,134.80
2,648.95
-1,514.15
-57.16%
Interest
136.76
238.94
-102.18
-42.76%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
998.04
2,410.01
-1,411.97
-58.59%
Depreciation
287.30
405.66
-118.36
-29.18%
Profit Before Tax
710.74
2,007.79
-1,297.05
-64.60%
Tax
200.51
427.80
-227.29
-53.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
510.23
1,576.55
-1,066.32
-67.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
510.23
1,576.55
-1,066.32
-67.64%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
-13.12
-7.70
-5.42
-70.39%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
492.37
1,570.19
-1,077.82
-68.64%
Equity Capital
189.43
40.06
149.37
372.87%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
17.27%
26.20%
0.00
-8.93%
PAT Margin
8.83%
17.14%
0.00
-8.31%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 3,103.73 Cr
in Dec 2024

Figures in Rs Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 177.57 Cr
in Dec 2024

Figures in Rs Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 384.64 Cr
in Dec 2024

Figures in Rs Cr
Nine Monthly - Interest
Interest 88.89 Cr
in Dec 2024

Figures in Rs Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.39%
in Dec 2024

Figures in Rs %